Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study
Mateus Paiva Marques Feitosa, Eduardo Gomes Lima, Alexandre Abizaid, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 15

Showing 15 citing articles:

Short-term effects of empagliflozin on preventing contrast induced acute kidney injury in patients undergoing percutaneous coronary intervention, a randomised trial
Zeinab Hosseini, Mohammad Javad Jamili, Behzad Ensan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Impact of using sodium-glucose cotransporter-2 inhibitors in patients undergoing percutaneous coronary intervention and incidence of contrast-induced nephropathy
Neelam Hassan, Mahmoud A. Tantawy, Ibrahim Younouss Abdelhamid, et al.
Tanta Medical Journal (2025) Vol. 53, Iss. 2, pp. 272-278
Closed Access
SGLT2 inhibitor improves the prognosis of patients with coronary heart disease and prevents in-stent restenosis
Qing Zhang, Zhiwen Deng, Tudi Li, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access | Times Cited: 3
Short term sodium glucose transport protein 2 inhibitors are associated with post contrast acute kidney injury in patients with diabetes
Jiabin Zang, Jianwen Liang, Xiaocong Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Efficacy of Chronic Use of Sodium–Glucose Co-transporter 2 Inhibitors on the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus Following Coronary Procedures: A Systematic Review and Meta-Analysis
Kyriakos Dimitriadis, Angeliki Vakka, Nikolaos Pyrpyris, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access | Times Cited: 3
Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms
Ronald Goldenberg, Jeremy Gilbert, Robyn L. Houlden, et al.
Current Medical Research and Opinion (2025), pp. 1-17
Closed Access
Risk of acute renal failure associated with combined use of SGLT2 inhibitors and potentially nephrotoxic drugs: an epidemiological surveillance study based on the FDA adverse event reporting system (FAERS)
Ting Yu, Jian Xiao, Mengyao Li, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis
Edinson Dante Meregildo-Rodríguez, Martha Genara Asmat-Rubio, Gustavo Adolfo Vásquez-Tirado
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
SGLT2 Inhibitors and the Risk of Contrast-Associated Nephropathy Following Angiographic Intervention: Contradictory Concepts and Clinical Outcomes
S Heyman, Doron Aronson, Zaid Abassi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10759-10759
Open Access | Times Cited: 3
Influence of sodium/glucose cotransporter-2 inhibitors on the incidence of acute kidney injury: a meta-analysis
Qian Wang, Jianmin Yu, Weizhu Deng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Protective Effect of SGLT2i on contrast-induced AKI after Angiography in Patients with Type 2 Diabetes Mellitus and Chronic Coronary Syndrome: A 6-year Ambispective Cohort Study and Meta-analysis
Zinan Zhao, Tianqi Zhang, Yatong Zhang, et al.
(2024)
Closed Access
The Incidence of Contrast-Induced Nephropathy in Patients on Sodium-Glucose Cotransporter-2 Inhibitors Following Percutaneous Coronary Intervention: An Observational Analysis
Emily Kefer, Brian Gulbis, Melanie Madorsky, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access
The Use of Sodium-Glucose Cotransporter-2 Inhibitors in Coronary Revascularization: Where Are We Now? A Systematic Review
Ryaan EL‐Andari, Nicholas M. Fialka, Jimmy J.H. Kang, et al.
American Journal of Cardiovascular Drugs (2023)
Closed Access | Times Cited: 1
Renal outcomes after contrast exposure in patients with diabetes who use sodium–glucose cotransporter 2 inhibitors
Chih‐Wei Chen, Fu-You Su, Pingping Wang, et al.
Postgraduate Medical Journal (2023) Vol. 100, Iss. 1181, pp. 142-150
Closed Access | Times Cited: 1
Sodium-glucose cotransporter 2 inhibitors and contrast-induced nephropathy risk: a meta-analysis
Gang Fan, Lin Lin, Hong Zuo, et al.
European Journal of Clinical Pharmacology (2024)
Closed Access
Page 1

Scroll to top